tomeko

Infantile-onset X-linked spinal muscular atrophy

Just diagnosed with Infantile-onset X-linked spinal muscular atrophy?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Infantile-onset X-linked spinal muscular atrophy, look for clinical trials, and connect with others living with it — all in one place.

Open the full Infantile-onset X-linked spinal muscular atrophy hub →

Overview

Infantile-onset X-linked spinal muscular atrophy is a rare condition. Also known as SMAX2, Spinal muscular atrophy with arthrogryposis, X-linked distal arthrogryposis multiplex congenita, X-linked spinal muscular atrophy type 2. Tomeko brings together the specialists, research, clinical trials, treatments and community for Infantile-onset X-linked spinal muscular atrophy so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:1145 · OMIM 301830 · ICD-10 G12.1 · GARD 0008521

Find care for Infantile-onset X-linked spinal muscular atrophy

Authoritative references for Infantile-onset X-linked spinal muscular atrophy

Common questions

I was just diagnosed with Infantile-onset X-linked spinal muscular atrophy — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Infantile-onset X-linked spinal muscular atrophy, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Infantile-onset X-linked spinal muscular atrophy?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Infantile-onset X-linked spinal muscular atrophy, filtered to your area.

Are there clinical trials for Infantile-onset X-linked spinal muscular atrophy?

Tomeko shows live, recruiting studies for Infantile-onset X-linked spinal muscular atrophy from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com